FLP Recombinase/Estrogen Receptor Fusion Proteins Require the Receptor D Domain for Responsiveness to Antagonists, but not Agonists
Author(s) -
Mark Nichols
Publication year - 1997
Publication title -
molecular endocrinology
Language(s) - English
Resource type - Journals
eISSN - 1944-9917
pISSN - 0888-8809
DOI - 10.1210/me.11.7.950
Subject(s) - biology , fusion protein , estrogen receptor , receptor , recombinase , ligand (biochemistry) , microbiology and biotechnology , binding domain , dna binding domain , transcription factor , biochemistry , binding site , genetics , gene , recombination , recombinant dna , cancer , breast cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom